Viewing Study NCT03924492


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2026-01-03 @ 8:14 PM
Study NCT ID: NCT03924492
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2025-09-15
First Post: 2019-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Protocol of ZULRESSOâ„¢ (Brexanolone) Injection for Adult Patients With Postpartum Depression
Sponsor: Supernus Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module